Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I study of intra-pleural administration of GL-ONC1, an oncolytic vaccinia virus, in patients with malignant pleural effusion
    Meeting Abstract

    Krug, L. M.; Zauderer, M. G.; Adusumili, P. S.; McGee, E.; Sepkowitz, K.; Klang, M.; Yu, Y. A.; Scigalla, P.; Rusch, V. W.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Assessing the performance of Watson for oncology, a decision support system, using actual contemporary clinical cases
    Meeting Abstract

    Kris, M. G.; Gucalp, A.; Epstein, A. S.; Seidman, A. D.; Fu, J.; Keesing, J.; Caroline, A.; Megerian, M.; Eggebraaten, T.; DeLima, R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Migration to next-generation sequencing and the identification of RET and ROS1 rearrangements plus PTEN and MET protein expression in tumor specimens from patients with lung adenocarcinomas: Lung Cancer Mutation Consortium (LCMC 2.0)
    Meeting Abstract

    Kris, M. G.; Johnson, B. E.; Kwiatkowski, D. J.; Wistuba, I. I.; Berry, L. D.; Haura, E. B.; Socinski, M. A.; Ramalingam, S. S.; Glisson, B. S.; Waqar, S. N.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase 1, open-label, dose-escalation study of SNX-5422 plus carboplatin and paclitaxel in subjects with advanced lung cancers
    Meeting Abstract

    Gutierrez, M.; Giaccone, G.; Harper, H. D.; Liu, S. V.; Fang, B.; Ruiz, J.; Hinson, J. M.; Orlemans, E. O.; Drilon, A. E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Electronic medical record as a research tool: Virtual clinical trial comparing pemetrexed and gemcitabine, both given with cisplatin, in patients with lung adenocarcinomas
    Meeting Abstract

    Grigorenko, A.; May, P.; Kastango, N.; Thaler, H. T.; Wagner, I.; Caroline, A.; Kris, M. G.; Zauderer, M. G.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • First-line monotherapy with nivolumab (NIVO; anti-programmed death-1 [PD-1]) in advanced non-small cell lung cancer (NSCLC): Safety, efficacy and correlation of outcomes with PD-1 ligand (PD-L1) expression
    Meeting Abstract

    Gettinger, S. N.; Hellmann, M. D.; Shepherd, F. A.; Antonia, S. J.; Brahmer, J. R.; Chow, L. Q. M.; Goldman, J. W.; Juergens, R. A.; Borghaei, H.; Ready, N.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II, open-label, multicenter study of the ALK inhibitor alectinib in an ALK+ non-small-cell lung cancer (NSCLC) US/Canadian population who had progressed on crizotinib (NP28761)
    Meeting Abstract

    Gandhi, L.; Shaw, A.; Gadgeel, S. M.; Riely, G.; Cetnar, J.; West, H. J.; Camidge, D. R.; Socinski, M. A.; Chiappori, A.; Mekhail, T.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Steps in developing Watson for Oncology, a decision support system to assist physicians choosing first-line metastatic breast cancer (MBC) therapies: Improved performance with machine learning
    Meeting Abstract

    Fu, J.; Gucalp, A.; Zauderer, M. G.; Epstein, A. S.; Kris, M. G.; Keesing, J.; Caroline, A.; Megerian, M.; Eggebraaten, T.; DeLima, R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Outcomes with chemotherapies and molecular characteristics of HER2-mutant lung cancers
    Meeting Abstract

    Eng, J.; Li, B. T.; Hsu, M.; Chaft, J. E.; Arcila, M. E.; Kris, M. G.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save